What is the recommended treatment for allergic rhinitis?

Treatment for Allergic Rhinitis

For initial treatment of allergic rhinitis in patients aged 12 years or older, start with intranasal corticosteroid monotherapy as first-line therapy. 1

Treatment Algorithm by Severity

Mild Intermittent or Mild Persistent Allergic Rhinitis

• Second-generation oral H1-antihistamines (cetirizine, fexofenadine, desloratadine, loratadine) OR intranasal antihistamines (azelastine, olopatadine) are appropriate first-line options 2
• These agents effectively reduce rhinorrhea, sneezing, and itching but have limited effect on nasal congestion 1
• Second-generation antihistamines are strongly preferred over first-generation agents due to significantly lower risk of sedation and performance impairment 1

Moderate to Severe or Persistent Allergic Rhinitis

• Intranasal corticosteroids (fluticasone, triamcinolone, budesonide, mometasone) are the most effective single medication class for controlling all four cardinal symptoms: sneezing, itching, rhinorrhea, and nasal congestion 1, 2
• Intranasal corticosteroids demonstrate superior efficacy compared to oral antihistamines, particularly for nasal congestion which is driven by type 2 inflammation 3

Key Treatment Principles

What NOT to Do

• Do not routinely add oral antihistamines to intranasal corticosteroids for initial treatment - this combination provides no additional benefit over intranasal corticosteroid monotherapy (strong recommendation) 1
• Do not use leukotriene receptor antagonists (montelukast) as first-line therapy - intranasal corticosteroids are significantly more effective, though montelukast may be considered in patients who refuse intranasal therapy or have concurrent mild persistent asthma 1

When to Escalate Treatment

For moderate to severe seasonal allergic rhinitis with inadequate response to monotherapy:

• Consider combination therapy with intranasal corticosteroid PLUS intranasal antihistamine (weak recommendation) 1
• Fixed-combination products (azelastine 548 mcg + fluticasone propionate 200 mcg) provide superior symptom reduction compared to either agent alone 1, 4
• This combination reduces total nasal symptom scores by approximately 40% more than monotherapy with either component 1
• Onset of action begins within 30 minutes 4

Important caveats for combination therapy:

• Higher potential for adverse effects including dysgeusia (bitter taste, 2.1-13.5% of users) and somnolence (0.4-1.1%) 1
• Greater cost compared to monotherapy 1
• The weak recommendation reflects that most patients would benefit, but many may reasonably decline due to side effects or cost 1

Adjunctive Therapies

Oral Decongestants

• Pseudoephedrine or phenylephrine reduce nasal congestion in both allergic and nonallergic rhinitis 1
• Beneficial when combined with antihistamines 1
• Monitor blood pressure in hypertensive patients due to interindividual variation in response 1

Topical Decongestants

• Limit use to 3 days maximum to prevent rhinitis medicamentosa (rebound congestion) 1
• Appropriate only for short-term use during acute exacerbations, viral infections, or eustachian tube dysfunction 1

Nasal Saline

• Safe, inexpensive, and effective for removing secretions, allergens, and mediators 3
• Hypertonic solutions provide decongestant activity 3

Disease-Modifying Treatment

Allergen-specific immunotherapy (subcutaneous or sublingual) is the only disease-modifying intervention available and should be considered for patients with moderate-to-severe allergic rhinitis, particularly those with inadequate response to pharmacotherapy 1, 5

Common Pitfalls to Avoid

• Avoid first-generation antihistamines - they cause significant sedation and anticholinergic effects (dry mouth, urinary retention) that patients may not subjectively perceive 1
• Instruct patients to direct intranasal sprays away from the nasal septum to minimize local irritation and epistaxis 1
• Continuous treatment is more effective than intermittent use for seasonal or perennial allergic rhinitis due to ongoing allergen exposure 1
• Do not assume pale turbinates confirm allergic rhinitis - nonallergic rhinitis can present with similar mucosal appearance 1

Real-World Evidence

Mobile health data demonstrates that patients using intranasal corticosteroid + intranasal antihistamine combinations require comedication on only 30-35% of days, compared to 45-60% for those using intranasal corticosteroids alone, suggesting superior real-world effectiveness 1